Medindia

X

Reportlinker Adds CA Tumor Markers: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

Wednesday, August 25, 2010 General News J E 4
Advertisement


NEW YORK, Aug. 25 Reportlinker.com announces that a new market research report is available in its catalogue:

CA Tumor Markers: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

http://www.reportlinker.com/p0269997/CA-Tumor-Markers-US-Europe-Japan---Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 278 pages and 40 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. CA Tumor Markers: Clinical Significance

and Laboratory Practices

B. Instrumentation Review And

Market Needs

1. Abbott AxSYM

2. Abbott IMx

3. Anagen AN2000/AuraFlex

4. Beckman Coulter Access

5. BioChem Pharma SR1

6. bioMerieux Vidas Series

7. Biotrol Systems 7000

8. J&J Diagnostics/Amersham Amerlite

9. J&J Diagnostics Vitros ECI

10. Olympus PK Series

11. Roche Cobas Core

12. Roche Elecsys

13. Roche ES 22

14. Roche ES 33

15. Roche ES 300/300 AL

16. Siemens ACS: 180

17. Siemens ACS: Centaur

18. Siemens ELISA Processor II/III

19. Siemens Immuno 1

20. Siemens/Opus/Plus/Magnum

21. Siemens Stratus

22. Tosoh AIA Series

23. Wallac/Pharmacia Delfia

C. Current and Emerging Technologies

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays

a. Technological Principle

b. Radioimmunoassay (RIA)

c. Enzyme Immunoassays (EIA)

- Overview

- ELISA

- Immunofiltration

- Particle-Membrane Capture Immunoassay

- Enzyme Amplification

d. Fluorescent Immunoassays

e. Luminescence

- Chemiluminescence

- Bioluminescence

3. Molecular Diagnostics

a. Technology Overview

b. Amplification Methods

- PCR

- DAP-PCR

- Immuno-PCR

- QC-PCR

- CAR

- DNA

- HPA

- LCR

- NASBA

- QBR

- SDA

- 3 SR, and others

4. Biochips/Microarrays

5. Chromosome Analysis

a. Chronic Myelogenous Leukemia (CML)

b. Acute Myeloid Leukemia (AML)

c. Acute Lymphoblastic Leukemia (ALL)

d. Malignant Lymphomas

Lymphoid Malignancies

e. Chronic Lymphocytic Leukemia (CLL)

f. Solid Cancers

6. Microcomputers and Automation

7. Artificial Intelligence

8. Flow Cytometry

9. Biosensors

D. Competing/Complementing Technologies

1. CT

2. MRI

3. NMR

4. PET

5.Photonics Spectroscopy

E. Personal Testing

III. France: Market Size, Growth and Major Suppliers' Sales

and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales

and Market Shares

V. Italy: Test Volume and Diagnostics Sales Forecast by

Market Segment

VI. Japan: Market Size, Growth and Major Suppliers' Sales

and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales

and Market Shares

VIII. U.K.: Test Volume and Diagnostics Sales Forecast by

Market Segment

IX. U.S.A.: Market Size, Growth and Major Suppliers' Sales

and Market Shares

X. Design Criteria for Decentralized Testing Products

XI. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation Factor

XII. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

XIII. Competitive Profiles

- Abbott

- AdnaGen

- Ambrilia Biopharma

- AMDL

- Beckman Coulter

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CanAG Diagnostics

- CeMines

- Cepheid

- Correlogic Systems

- Dako

- Decode

- Diadexus

- Diagnocure

- Diasorin

- Eiken Chemical

- Enterix

- Enzo Biochem

- Epigenomics

- Exact Sciences

- Fujirebio

- Gen-Probe

- Guided Therapeutics

- Hologic

- Ipsogen

- J&J Diagnostics

- Kreatech

- Kyowa Medex

- Mackay Life Sciences

- Matritech

- Myriad Genetics

- OncoLab

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac

- Zila

List of Tables

Major Companies Developing or Marketing CA 15-3/27.29 Tests

Major Companies Developing or Marketing CA 19-9 Tests

Major Companies Developing or Marketing CA 125 Tests

France

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

France

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

France

CA 125 Test Volume and Diagnostics Sales by Market

Segment

France

CA 15-3/27.29 Testing Market by Major Supplier

France

CA 19-9 Testing Market by Major Supplier

France

CA 125 Testing Market by Major Supplier

Germany

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

Germany

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

List of Tables (continued)

Germany

CA 125 Test Volume and Diagnostics Sales by Market

Segment

Germany

CA 15-3/27.29 Testing Market by Major Supplier

Germany

CA 19-9 Testing Market by Major Supplier

Germany

CA 125 Testing Market by Major Supplier

Italy

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

Italy

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

Italy

CA 125 Test Volume and Diagnostics Sales by Market

Segment

Japan

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

Japan

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

Japan

CA 125 Test Volume and Diagnostics Sales by Market

Segment

Japan

CA 15-3/27.29 Testing Market by Major Supplier

List of Tables (continued)

Japan

CA 19-9 Testing Market by Major Supplier

Japan

CA 125 Testing Market by Major Supplier

Spain

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

Spain

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

Spain

CA 125 Test Volume and Diagnostics Sales by Market

Segment

Spain

CA 15-3/27.29 Testing Market by Major Supplier

Spain

CA 19-9 Testing Market by Major Supplier

Spain

CA 125 Testing Market by Major Supplier

U.K.

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

U.K.

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

U.K.

CA 125 Test Volume and Diagnostics Sales by Market

Segment

List of Tables (continued)

U.S.A.

CA 15-3/27.29 Test Volume and Diagnostics Sales by Market

Segment

U.S.A.

CA 19-9 Test Volume and Diagnostics Sales by Market

Segment

U.S.A.

CA 125 Test Volume and Diagnostics Sales by Market

Segment

U.S.A.

CA 15-3/27.29 Testing Market by Major Supplier

U.S.A.

CA 19-9 Testing Market by Major Supplier

U.S.A.

CA 125 Testing Market by Major Supplier

To order this report:

Diagnostics Industry: CA Tumor Markers: US, Europe, Japan - Test Volume, Sales Forecasts and Supplier Shares by Country

Diagnostics Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Analytical Tool - Protein Kinase...
S
HART Health Launches Franchise System and Expands ...